Vista Oncology is a clinical research site located in Olympia, Washington, United States 98502.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Vista Oncology has participated in 6 clinical trials with 4 currently active.
Therapeutic areas: Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma.
Sponsors: Astellas Pharma Global Development, Inc., Oncotherapeutics, Stemline Therapeutics, Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Vista Oncology has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vista Oncology has 6 clinical trials on record, with 4 currently active. Their work covers Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma.
Yes — Vista Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.